Navigasi
Pandangan Pasar Penyaring Saham Kalender Dividen Kalender acara Peringkat saham Berita Pasar
Coba gratis

Gritstone Oncology

NASDAQ GRTS
$0.84 0.01 1.51%
Today share price
Amerika Serikat
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 13 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

99.70M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
81.46M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.09
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
118.39M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-58.72 %

Upcoming events Gritstone Oncology

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Gritstone Oncology

Stock analysis Gritstone Oncology

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.69 28.60
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
1.92 4.18
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.55 11.39
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.12 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-1,037.62 10.75

Price change Gritstone Oncology per year

2.54$ 28.52$
Min Max

Summary analysis Gritstone Oncology

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Gritstone Oncology

Revenue and net income Gritstone Oncology

All parameters

Stock news Gritstone Oncology

All news

About company Gritstone Oncology

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was founded in 2015 and is headquartered in Emeryville, California.
Address:
5959 Horton Street, EmeryVille, CA, United States, 94608
Company name: Gritstone Oncology
Issuer ticker: GRTS
ISIN: US39868T1051
Country: Amerika Serikat
Exchange: NASDAQ
Currency: $
IPO date: 2018-09-28
Sector: Healthcare
Industry: Biotechnology
Site: https://gritstonebio.com

On which stock exchange are Gritstone Oncology (GRTS) stocks traded?

Gritstone Oncology (GRTS) stocks are traded on NASDAQ.

What is the ticker of Gritstone Oncology stocks (GRTS)?

The stock ticker of Gritstone Oncology’s stocks or in other words, the code is GRTS. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Gritstone Oncology (GRTS) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Gritstone Oncology (GRTS) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Gritstone Oncology (GRTS) stocks traded?

Gritstone Oncology (GRTS) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Gritstone Oncology (GRTS) stocks today?

The current price of Gritstone Oncology stocks on 23.05.2024 is 0.8421 dollars. per share.

What is the dynamics of Gritstone Oncology (GRTS) stocks from the beginning of the year?

Gritstone Oncology (GRTS) quotes have increased by -61.37% from the beginning of the year up to 0.8421 dollars. per 1 stocks.

How much did Gritstone Oncology (GRTS) stocks increase in мае 2024?

This month Gritstone Oncology (GRTS) quotes have increased by -3.62% to 0.8421 dollars. per share.

How much are Gritstone Oncology (GRTS) stocks worth?

Today, on October, 23.05.2024 Gritstone Oncology’s (GRTS) stocks cost 0.8421 dollars..

What is the market capitalization of Gritstone Oncology (GRTS)?

Capitalization is the market value of Gritstone Oncology (GRTS) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 23.05.2024, the market capitalization of Gritstone Oncology (GRTS) is estimated at about 99697250 dollars.